Vascular endothelial growth factor (VEGF) is a predictable marker for FEV1 progression in patients with Lymphangiolyomyomatosis (LAM).

J. Freise (Hannover, Germany), M. Klingenberg (Hannover, Germany), J. Fuge (Hannover, Germany), T. Welte (Hannover, Germany)

Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Freise (Hannover, Germany), M. Klingenberg (Hannover, Germany), J. Fuge (Hannover, Germany), T. Welte (Hannover, Germany). Vascular endothelial growth factor (VEGF) is a predictable marker for FEV1 progression in patients with Lymphangiolyomyomatosis (LAM).. 3685

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: